Search results
AstraZeneca's COVID-19 Prevention Therapy Cuts Risk Of Infection In Patients With Weaker Immunity,...
Benzinga via Yahoo Finance· 1 day agoThursday, AstraZeneca Plc (NASDAQ:AZN) released high-level results from the SUPERNOVA Phase 3...
7 Blue-Chip Stocks to Protect Your Wealth as the Economy Slows
InvestorPlace· 2 days agoFor Q1 2024, GDP growth in the United States decelerated to 1.6% from 3.4% in the last quarter. At...
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Motley Fool via Yahoo Finance· 5 days agoJohnson & Johnson should trade at more of a discount In terms of valuation, AstraZeneca is a...
Equities Analysts Offer Predictions for AstraZeneca PLC’s Q2 2024 Earnings (NASDAQ:AZN)
ETF DAILY NEWS· 2 days agoAstraZeneca PLC (NASDAQ:AZN – Free Report) – Research analysts at Zacks Research reduced their Q2 2024 earnings per share estimates for AstraZeneca in a ...
Roche (RHHBY) Posts Encouraging Phase I Obesity Drug Data
Zacks via Yahoo Finance· 1 day agoData from the study shows that nearly half of the patients who received Roche's (RHHBY)...
5 Top Vanguard Mutual Funds Amid Volatile Market Conditions
Zacks via Yahoo Finance· 2 days agoMost of the fund’s exposure was in companies like Eli Lilly (7.6%), UnitedHealth Group (6.9%) and ...
Healthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare Sector - ...
Benzinga· 4 days agoPfizer and AstraZeneca invest over $1 billion in France's healthcare sector, bolstering R&D...
7 Pharma Stocks Harnessing AI Brainpower for Big Breakthroughs
InvestorPlace· 2 days agoIt’s no secret that artificial intelligence (AI) promises to transform every industry and sector,...
Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study
Zacks via Yahoo Finance· 4 days agoBristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...
Earnings call: AIM ImmunoTech highlights Q1 2024 progress on cancer trials
Investing.com· 2 days agoAIM ImmunoTech (NYSE: AIM ) Inc. (NYSE American: AIM) provided an optimistic update during its first...